|
|
|
Effectiveness of fractional CO2 laser in women with stress urinary incontinence |
Mahin Najafian, Yalda Jafrideh, Behnaz Ghazisaeidi( ) |
| Fertility, Infertility and Perinatology Research Center, Ahavaz Jundishapur University of Medical Sciences, Ahvaz, Iran |
|
|
|
|
Abstract BACKGROUND: Stress urinary incontinence (SUI) is a relatively common disorder that significantly affects the quality of life. Many conservative and surgical treatment methods have been recommended for SUI, but they have major limitations. AIMS: To assess the use of the CO2 fractional laser in the treatment of SUI. METHODS: This clinical trial included 55 patients with confirmed SUI. Patients underwent fractional CO2 laser treatment 3 times at 30-day intervals. Data on age, smoking history, sexual activity, menopause, and history of hormone replacement therapy (HRT) were collected. Response to treatment was assessed by SUI severity and the level of sexual satisfaction was assessed using the visual analog scale (VAS). Patients were evaluated at 3 different time points: before treatment, and 45 days and 6 months after the last laser treatment. RESULTS: The mean patient age was 44.4±11.4 years (range: 28 to 68 years). Smoking history was positive in 6 patients (9.1%); 19 (54.3%) were menopausal on HRT. The SUI severity score at baseline (before treatment) was 8.56±0.62 and decreased to 2.28 6 months after treatment (p<0.0001). The sexual satisfaction score was 3±0.94 at baseline and increased to 7.87±0.93 6 months after treatment (day 180) (p<0.0001, slope= + 2.2) CONCLUSION: Our findings are in line with a previous study that showed the value of transvaginal CO2 fractional laser treatment for alleviation of SUI symptoms and its potential as an alternative treatment. We also observed improved sexual satisfaction in SUI patients.
|
| Keywords
stress urinary incontinence
CO2 fractional laser
sexual function
|
|
Corresponding Author(s):
Behnaz Ghazisaeidi
|
|
Online First Date: 09 May 2018
Issue Date: 28 May 2018
|
|
| 1 |
Fistonić N, Fistonić I, Guštek Š F, Turina I S, Marton I, Vižintin Z, Kažič M, Hreljac I, Perhavec T, Lukač M (2016). Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci, 31(4): 635–643; Epub ahead of print
https://doi.org/10.1007/s10103-016-1884-0
pmid: 26861984
|
| 2 |
Isaza P G, Jaguszewska K, Cardona J L, Lukaszuk M (2017). Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J Pelvic Floor Dysfunct, 29 (2) :1–5
|
| 3 |
Kavanagh A, Sanaee M, Carlson K V, Bailly G G (2017). Management of patients with stress urinary incontinence after failed midurethral sling. Can Urol Assoc J, 11(6Suppl2): S143–S146
https://doi.org/10.5489/cuaj.4610
pmid: 28616115
|
| 4 |
Kociszewski J, Fabian G, Grothey S, Kuszka A, Zwierzchowska A, Majkusiak W, Barcz E (2017). Are complications of stress urinary incontinence surgery procedures associated with the position of the sling? Int J Urol, 24(2): 145–150
https://doi.org/10.1111/iju.13262
pmid: 27907976
|
| 5 |
Luber K M (2004). The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol, 6(Suppl 3): S3–S9
pmid: 16985863
|
| 6 |
Menachem A, Alexander B, Martinec K A, Gutman G (2016). The effect of vaginal CO2 laser treatment on stress urinary incontinence symptoms. Alma Surgical.
|
| 7 |
Nygaard I E, Heit M (2004). Stress urinary incontinence. Obstet Gynecol, 104(3): 607–620
https://doi.org/10.1097/01.AOG.0000137874.84862.94
pmid: 15339776
|
| 8 |
Pardo J I, Solà V R, Morales A A (2016). Treatment of female stress urinary incontinence with Erbium-YAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol, 204: 1–4
https://doi.org/10.1016/j.ejogrb.2016.06.031
pmid: 27448169
|
| 9 |
Park S H, Kang C B (2014). Effect of kegel exercises on the management of female stress urinary incontinence: A systematic review of randomized controlled trials. Advan Nur, 2014 (4) :1–10
|
| 10 |
Pitsouni E, Grigoriadis T, Falagas M E, Salvatore S, Athanasiou S (2017). Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis. Maturitas, 103: 78–88
https://doi.org/10.1016/j.maturitas.2017.06.029
pmid: 28778337
|
| 11 |
Pitsouni E, Grigoriadis T, Tsiveleka A, Zacharakis D, Salvatore S, Athanasiou S (2016). Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: An observational study. Maturitas, 94: 131–136
https://doi.org/10.1016/j.maturitas.2016.09.012
pmid: 27823733
|
| 12 |
Salvatore S, Nappi R E, Parma M, Chionna R, Lagona F, Zerbinati N, Ferrero S, Origoni M, Candiani M, Leone Roberti Maggiore U (2015). Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy. Climacteric, 18(2): 219–225
https://doi.org/10.3109/13697137.2014.975197
pmid: 25333211
|
| 13 |
Ulmsten U, Falconer C (1999). Connective tissue in female urinary incontinence. Curr Opin Obstet Gynecol, 11(5): 509–515
https://doi.org/10.1097/00001703-199910000-00017
pmid: 10526931
|
| 14 |
van Kerrebroeck P, ter Meulen F, Farrelly E, Larsson G, Edwall L, Fianu-Jonasson A (2003). Treatment of stress urinary incontinence: recent developments in the role of urethral injection. Urol Res, 30(6): 356–362
pmid: 12599014
|
| 15 |
Zhou S, Zhang K, Atala A, Khoury O, Murphy SV, Zhao W, Fu Q (2016). Stem cell therapy for treatment of stress urinary incontinence: the current status and challenges. Stem Cell Intern, 2016 (3) :7060975
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
| |
Shared |
|
|
|
|
| |
Discussed |
|
|
|
|
